397 related articles for article (PubMed ID: 9841917)
1. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs.
Müller M; Wilder S; Bannasch D; Israeli D; Lehlbach K; Li-Weber M; Friedman SL; Galle PR; Stremmel W; Oren M; Krammer PH
J Exp Med; 1998 Dec; 188(11):2033-45. PubMed ID: 9841917
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.
Müller M; Strand S; Hug H; Heinemann EM; Walczak H; Hofmann WJ; Stremmel W; Krammer PH; Galle PR
J Clin Invest; 1997 Feb; 99(3):403-13. PubMed ID: 9022073
[TBL] [Abstract][Full Text] [Related]
3. The role of p53 and the CD95 (APO-1/Fas) death system in chemotherapy-induced apoptosis.
Müller M; Scaffidi CA; Galle PR; Stremmel W; Krammer PH
Eur Cytokine Netw; 1998 Dec; 9(4):685-6. PubMed ID: 9889415
[TBL] [Abstract][Full Text] [Related]
4. Characterization of p53-mediated up-regulation of CD95 gene expression upon genotoxic treatment in human breast tumor cells.
Ruiz-Ruiz C; Robledo G; Cano E; Redondo JM; Lopez-Rivas A
J Biol Chem; 2003 Aug; 278(34):31667-75. PubMed ID: 12788915
[TBL] [Abstract][Full Text] [Related]
5. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
6. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
Ruiz-Ruiz MC; López-Rivas A
Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
[TBL] [Abstract][Full Text] [Related]
7. Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma.
Ramp U; Dejosez M; Mahotka C; Czarnotta B; Kalinski T; Wenzel M; Lorenz I; Müller M; Krammer P; Gabbert HE; Gerharz CD
Br J Cancer; 2000 Jun; 82(11):1851-9. PubMed ID: 10839301
[TBL] [Abstract][Full Text] [Related]
8. Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy.
Stahnke K; Fulda S; Friesen C; Strauss G; Debatin KM
Blood; 2001 Nov; 98(10):3066-73. PubMed ID: 11698292
[TBL] [Abstract][Full Text] [Related]
9. CD95 ligand induces senescence in mismatch repair-deficient human colon cancer via chronic caspase-mediated induction of DNA damage.
Raats DA; Frenkel N; van Schelven SJ; Rinkes IH; Laoukili J; Kranenburg O
Cell Death Dis; 2017 Mar; 8(3):e2669. PubMed ID: 28300842
[TBL] [Abstract][Full Text] [Related]
10. Active transcription of the human FAS/CD95/TNFRSF6 gene involves the p53 family.
Schilling T; Schleithoff ES; Kairat A; Melino G; Stremmel W; Oren M; Krammer PH; Müller M
Biochem Biophys Res Commun; 2009 Sep; 387(2):399-404. PubMed ID: 19615968
[TBL] [Abstract][Full Text] [Related]
11. A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs.
Eichhorst ST; Müller M; Li-Weber M; Schulze-Bergkamen H; Angel P; Krammer PH
Mol Cell Biol; 2000 Oct; 20(20):7826-37. PubMed ID: 11003676
[TBL] [Abstract][Full Text] [Related]
12. CD95 is part of a let-7/p53/miR-34 regulatory network.
Hau A; Ceppi P; Peter ME
PLoS One; 2012; 7(11):e49636. PubMed ID: 23166734
[TBL] [Abstract][Full Text] [Related]
13. Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis.
Munsch D; Watanabe-Fukunaga R; Bourdon JC; Nagata S; May E; Yonish-Rouach E; Reisdorf P
J Biol Chem; 2000 Feb; 275(6):3867-72. PubMed ID: 10660538
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic drugs and the CD95 pathway.
Friesen C; Fulda S; Debatin KM
Leukemia; 1999 Nov; 13(11):1854-8. PubMed ID: 10557062
[TBL] [Abstract][Full Text] [Related]
15. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
Pohl U; Wagenknecht B; Naumann U; Weller M
Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342
[TBL] [Abstract][Full Text] [Related]
16. α-TEA cooperates with chemotherapeutic agents to induce apoptosis of p53 mutant, triple-negative human breast cancer cells via activating p73.
Tiwary R; Yu W; Sanders BG; Kline K
Breast Cancer Res; 2011 Jan; 13(1):R1. PubMed ID: 21214929
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression.
Zhou M; Gu L; Yeager AM; Findley HW
Leukemia; 1998 Nov; 12(11):1756-63. PubMed ID: 9823951
[TBL] [Abstract][Full Text] [Related]
18. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells.
Fulda S; Susin SA; Kroemer G; Debatin KM
Cancer Res; 1998 Oct; 58(19):4453-60. PubMed ID: 9766678
[TBL] [Abstract][Full Text] [Related]
19. Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics.
Roth W; Fontana A; Trepel M; Reed JC; Dichgans J; Weller M
Cancer Immunol Immunother; 1997 Mar; 44(1):55-63. PubMed ID: 9111585
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism.
Lorenzo E; Ruiz-Ruiz C; Quesada AJ; Hernández G; Rodríguez A; López-Rivas A; Redondo JM
J Biol Chem; 2002 Mar; 277(13):10883-92. PubMed ID: 11779855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
